Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ELP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOCS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996740 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATG2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMLHE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYTH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDAH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D22B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CMC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on